Crossmark

FDA Black Box Warning for SSRI: Reexamining the Role of High-Functioning Autism as a Confounder

Crossref DOI link: https://doi.org/10.1007/s41252-022-00301-6

Published Online: 2022-10-26

Published Print: 2023-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gupta, Mayank https://orcid.org/0000-0002-0521-1419
Gupta, Nihit
License Information

Text and Data Mining valid from 2022-10-26

Version of Record valid from 2022-10-26
More Information

Article History

Accepted: 18 October 2022

First Online: 26 October 2022

Declarations

:

: None.

: Not applicable.

: The authors declare no competing interests.